Author: Dr. Jonathan Kenigson, FRSA
The Israeli healthcare system embodies a tradition of productive contradiction. Citizens enjoy a life expectancy of 82.5 years—among the highest globally [1]—while maintaining an exceptional 90% patient satisfaction rate [2]. Such outcomes would ordinarily signal a well-functioning system, yet beneath these impressive statistics lies a network of structural vulnerabilities that demand serious analytical attention. Consider the numerical portrait: Israel secures 12th position in the 2024 World Index of Healthcare Innovation with an overall score of 50.62 [3], a respectable showing that nonetheless obscures troubling fiscal realities. Healthcare expenditure represents merely 7.4% of GDP, substantially below the 8.9% OECD average [1]. More concerning is the composition of this spending—public funds account for only 63% of total health expenditures, contrasted with 73.5% across OECD nations [1]. This financing structure creates what economists would recognize as accessibility constraints, manifested through elevated out-of-pocket expenses and catastrophic health expenditures affecting needy citizens [3].
Israel maintains a younger population profile relative to most OECD countries [4], yet faces accelerating healthcare demand driven by concurrent population growth and aging trends [4]. These pressures coincide with workforce challenges, particularly the impending retirement of highly-skilled healthcare professional cohorts. The severity of this human capital shortage becomes evident in a stark statistic: merely 3.7% of medical students express interest in both primary care practice and service in peripheral regions [5]. What follows constitutes an examination of why Israel’s healthcare infrastructure requires systematic attention during the remaining legislative session in 2025. The analysis encompasses current systemic strengths, financial structural imbalances, operational challenges within dual-practice arrangements, and potential pathways for meaningful reform. Such investigation proves necessary not merely for Israeli policymakers, but for any observer seeking to understand how healthcare systems maintain performance standards while confronting resource constraints and demographic pressures.
Systematic Assessment of Israeli Healthcare Performance
Healthcare systems typically demonstrate strong correlations between expenditure levels and population health outcomes. Israel presents a noteworthy exception to this general principle. The nation achieves population health metrics that would ordinarily require higher per-capita healthcare investment, suggesting either exceptional system efficiency or unique structural advantages. The mathematics of Israeli healthcare efficiency becomes particularly interesting when one examines the four competing health maintenance organizations that comprise the system’s foundation. These entities, established through the 1995 national health insurance framework, create competitive dynamics while maintaining universal coverage—a combination that economic theory suggests should produce both efficiency gains and service quality improvements. Family-centered care models dominate Israeli healthcare delivery, particularly within maternal and infant health services. The comprehensive nature of prenatal and postnatal programs contributes measurably to population health statistics. One may observe that such systematic approaches to population health management often yield outcomes that exceed those achieved through more fragmented, specialist-driven care models common in other healthcare systems.
The designation of Israel as a “Start-Up Nation” extends meaningfully into healthcare delivery systems. Electronic health record implementation preceded similar adoptions in most developed nations by significant time periods, creating information infrastructure that enables coordination mechanisms rarely observed elsewhere. I’ve found it instructive that Israeli healthcare innovation emerges from systematic partnerships between academic institutions, healthcare providers, and private industry. Such collaboration patterns produce technological solutions addressing both domestic needs and global healthcare challenges—from telemedicine applications for geographically dispersed populations to artificial intelligence diagnostic tools. The comprehensive digitization of patient records creates vast datasets suitable for population health research and individualized treatment optimization.
Israeli researchers employ these information resources to identify epidemiological trends, develop prevention strategies, and customize therapeutic approaches based on demographic characteristics and medical histories. Such data-driven healthcare represents a model that other nations attempt to replicate with varying degrees of success. This performance suggests that healthcare delivery effectiveness depends more heavily on structural organization and operational efficiency than on absolute funding levels—a conclusion that challenges conventional assumptions about healthcare resource requirements.
International health policy analysts study the Israeli model specifically to understand mechanisms that produce exceptional value relative to investment. Such hybrid approaches balance public funding with competitive service delivery in ways that pure market or pure government systems often cannot achieve. Yet these impressive comparative rankings obscure growing tensions within the system’s architecture. The sustainability of Israeli healthcare excellence depends critically on addressing structural challenges, particularly the evolving balance between public and private financing mechanisms. Maintaining performance standards that earned international recognition will require strategic reform and appropriate investment—a challenge that becomes more pressing as demographic and economic pressures intensify.
Demographic Convergence: Multiple Pressures Strain System Capacity
Most OECD countries grapple with aging populations amid declining fertility; Israel faces simultaneous expansion at both extremes of the age distribution—a pattern that generates unprecedented healthcare demands. Current demographic data reveals the scope of this convergence. The elderly population numbers 1.2 million, with approximately 39,000 Israelis entering the 65-and-over cohort annually [6]. Those aged 80 and older represent the fastest-expanding segment [6]. The proportion of Israelis aged 65 or older has risen from 11% a decade ago to 13% currently, with projections indicating growth to at least 14% by 2040 [6].
Israel simultaneously maintains a total fertility rate of 3.1 children per woman—the highest among OECD countries [7]. Even among Jewish women identifying as secular or traditional but not religious, the combined fertility rate exceeds 2.2 [7]. This creates what demographers would recognize as a resource allocation dilemma: healthcare infrastructure must serve expanding populations of both the very young and very old [1].
Epidemiological patterns in Israel align closely with global trends, though certain metrics warrant particular attention. Seven out of ten deaths annually result from chronic diseases [8]. Heart disease and cancer together accounted for 42% of total mortality in 2011 [8]. The most troubling trend involves multiple chronic conditions (MCC), which increased by 6.7% between 2003-2004 and 2014-2015 and show continued trends of acceleration [9]. Lifestyle factors drive much of this burden. Currently, 52.6% of men and 44.5% of women are overweight or obese, while physical inactivity affects 63.9% of men and 69.4% of women [8]. These patterns contribute to Israel’s concerning position regarding metabolic disorders—high blood sugar levels cause approximately 61% more disease burden than European averages [10]. Obesity generates about 21% greater disease burden compared to European norms [10].Specific prevalence rates illustrate the challenge: dyslipidemia affects 29.6% of adults, hypertension 20.6%, diabetes 9.3%, and thyroid disease 8.9% [11]. Cancer prevalence has surged by a staggering 76% in recent years, with dyslipidemia following closely at a 75.1% increase [11]. Approximately one-third of Israel’s population—nearly 2.8 million—consists of children under 18 years [12].
Despite maintaining only 0.8 pediatricians per 1,000 children [12], the system must address both traditional pediatric conditions and emerging health challenges. Healthcare providers increasingly encounter what specialists term “new morbidities”—childhood obesity, developmental disabilities, and mental health concerns [12]. Various estimates suggest over 20% of children visiting community pediatric clinics present with one of these emerging issues [12].Geographic disparities compound these pressures. Research demonstrates that residents in Israel’s periphery forego medical services significantly more than those in central regions (OR = 1.42) [13]. Such imbalances create particular hardships for families seeking specialized maternal and pediatric services[13].
Healthcare expenditure in Israel reflects a striking parsimony—7.4% of GDP allocated to health services represents a figure below both the 8.9% OECD average and the 11.0% typical among nations with comparable HMO-based architectures [1]. This modest allocation becomes particularly troublesome when considered alongside the demographic pressures identified earlier. The funding gap has expanded consistently over time, creating what can only be characterized as a widening chasm between Israel’s health expenditure and that of comparable nations [1]. Historical examination of financing structure reveals deliberate policy choices that foundationally altered the system’s basis.
The National Health Insurance Law of 1994-95 established healthcare financing through an earmarked health tax (4.8% of income), employer contributions, and direct government allocations [14]. Subsequent legislative modifications systematically dismantled this tripartite structure. The elimination of employer contributions in 1997 [14] preceded an even more significant change in 1998, when the government abandoned its commitment to bridge funding shortfalls, substituting instead significantly reduced fixed annual allocations [14].Government withdrawal from healthcare financing has proceeded with remarkable consistency since 1998 [14]. Public spending now constitutes approximately 60% of national health expenditure as of 2014 [14]—a figure that stands in stark contradiction to the 73.5% average among OECD nations [1] and the 78% typical in countries with healthcare systems structurally analogous to Israel’s [1]. The arithmetic of this transformation proves illuminating: between 1995 and 2010, public financing expanded by merely 11.7%, while private financing surged by 51.6% [14].
Such figures document deliberate policy redirection that shifts healthcare costs from governmental to individual responsibility. Individual healthcare expenditure now represents approximately 20% of total health spending—exceeding the 18% OECD average [15]. Household health expenditure has grown from 3.8% of total household spending in 1997 to 5.1% by 2009 [14], reflecting the concrete impact of these policy choices on family budgets. Most remarkable is the expansion of private insurance coverage. Israel now maintains one of the highest private health insurance ownership rates globally, with 80% of the population purchasing supplementary coverage [14]. Citizens spent 1.5 billion euros on private insurance by 2013 [14], a figure that reflects diminishing confidence in the public system’s capacity to deliver necessary services during serious illness [16].
This financing transformation threatens the egalitarian principles originally embedded in Israeli healthcare policy [17]. Healthcare spending inequality has become pronounced—the wealthiest quintile expends 3.6 times more on healthcare than the poorest quintile [14]. Such disparities create what experts appropriately characterize as “an ungainly hybrid with no clear distinction between public and private”[17], operating without adequate regulatory framework. The privatization trend directly contradicts the foundational principles of the 1994 National Health Insurance Law, which explicitly recognized healthcare as a right and emphasized equal access [14]. Without strategic intervention, the expanding funding gap will continue undermining these commitments, transforming a system once celebrated for its egalitarian character into one increasingly stratified by economic means (Kenigson 2025).
Dual Practice: The Ethical Morass
The structural financing problems examined above manifest most visibly through dual practice arrangements—a phenomenon that corrupts the integrity of Israeli healthcare delivery. Physicians employed within government or non-profit hospitals routinely establish fee-for-service practices in private facilities during late afternoon and evening hours [18]. This arrangement, particularly prevalent among surgical specialists, operates under a regulatory framework so permissive that hospital directors grant permission as administrative routine rather than meaningful oversight [18]. The most pernicious aspect of this system involves self-referrals—physicians directing patients from public clinics to their private practices. One encounters here a textbook example of how information asymmetries enable professional self-interest to supersede patient welfare. Research conducted at Jerusalem hospitals demonstrates the stark consequences: average waiting times for specialist appointments extend 14 times longer for public versus private consultations at Hadassah Hospital, with Shaare Zedek Hospital showing five-fold disparities [14].These patterns reflect what economists term supplier-induced demand—circumstances where physicians influence patients to consume services beyond medical necessity [19]. Subsequent investigation reveals that dual-practice physicians demonstrate stronger commitment to patients who pay directly [20]. More troubling still, such physicians express significantly greater agreement than their public-only colleagues that “patients who can afford treatment deserve higher access to health services” [20].
The corruption of medical judgment manifests through unnecessary procedures and diagnostic testing. Women with private insurance face significantly higher odds of Cesarean sections when compared to their publicly insured counterparts [14]. Similarly, private insurance holders routinely undergo duplicate testing and consultations—indeed, 63% of patients seeking second opinions pursue them within the private system [21]. Public hospitals suffer reduced afternoon availability of senior specialists, who depart for private facility obligations [18]. This exodus places increased burden on residents and interns, systematically degrading the institution’s capacity to manage complex cases [18]. Concurrently, public hospitals lose both revenue and market share in profitable elective procedures [18].The resulting dynamic forces public institutions into competition for their own staff—a perverse arrangement that drove physician wages upward by 42% between 2011-2017, compared to merely 15% for average wages [1]. These pressures create regional and specialty imbalances, making physician recruitment to peripheral regions and less lucrative specialties like family medicine increasingly difficult [18].
Structural Reform: Two Paradigmatic Approaches
Contemporary analysis of Israeli healthcare reveals that incremental adjustments prove insufficient for addressing systemic contradictions. Policy experts have consequently developed two distinct reform paradigms, each representing a different philosophical approach to resolving the public-private tension. One framework mandates complete operational separation between public and private healthcare delivery. Public financing would consolidate the standard health tax with supplementary insurance collections, thereby expanding coverage beyond the current basic basket [22]. Under this arrangement, any institution contracted for entitled care receives classification as “public” irrespective of ownership structure. Citizens desiring private care would secure services through commercial insurance or direct payment [22].The most significant provision eliminates dual practice entirely—healthcare workers receiving public funding would commit exclusively to the public system as full-time employees [22]. Such arrangements would resolve the ethical conflicts that currently plague physician decision-making and patient referral patterns.
A more conservative alternative approach merges existing systems into a cohesive structure while maintaining tiered access. Every resident would receive basic public insurance that combines current standard and supplementary coverages [22]. Private services would operate through an additional tier funded entirely by individual contributions [22].
The distinguishing characteristic of this model lies in service delivery integration—elective procedures would occur within the same institutional framework as public services, with supplementary insurance covering additional amenities rather than expedited access [22]. This arrangement preserves choice while eliminating the most egregious inequities in waiting times and service availability.
Both proposed models require abandonment of Israel’s current “ungainly hybrid” system [1]. Recent Ministry of Health initiatives, including accelerated drug registration processes and workforce expansion through three new medical schools opening in 2025, suggest recognition of these structural necessities [23].The choice between these paradigms ultimately reflects competing values regarding healthcare equity, professional autonomy, and resource allocation. Neither approach offers simple solutions to the tension between universal access and individual choice. Success for either model demands comprehensive re-examination of incentive structures, regulatory frameworks, and professional obligations [1]. Such systematic reform cannot occur through piecemeal legislative adjustments but requires sustained political commitment to healthcare system restructuring.
Reflections on a System at Risk
Physicians who accept public salaries while operating private practices create what economists might call moral hazard, but what ordinary citizens experience as betrayal. When waiting times for specialist appointments become fourteen times longer in public versus private consultations, the principle of equal access becomes meaningless rhetoric. Yet current policy responses suggest a preference for market solutions over systematic planning. This approach may prove particularly shortsighted given the specialized needs of both pediatric and geriatric populations. Time operates as the most unforgiving constraint in healthcare policy. Systems can deteriorate rapidly once confidence erodes, yet rebuilding trust requires sustained commitment over decades. Israel’s healthcare infrastructure benefited from the idealistic vision of its founders, who understood that universal access required continuous financial and moral support. The stakes extend beyond Israel’s borders. Healthcare systems worldwide grapple with similar tensions between public goods and private markets. Israel’s experience offers valuable lessons about the dangers of incremental privatization and the importance of maintaining clear philosophical commitments. Whether these lessons will be learned remains an open question, one that the next several years may definitively answer.
A Note to the Knesset and Rabbinate: I (Jonathan Kenigson) am an ardent supporter of healthcare equity in the USA and Israel. I’ve made similar cases for healthcare reform in Tennessee and Kansas. No US state has a health system as comprehensive or efficient as the Israeli system. I recognize and support the diligent efforts of Israeli physicians and hospital administrators in light of the rapidly evolving legal and political landscape.
Legal Disclaimer: This article is syndicated from independent third-party sources. Kyrion Media makes no warranty as to accuracy, legality, or reliability. For complaints or copyright concerns, contact [email protected] with the article URL.
